Direkt zum Inhalt
Merck

Convergence of multiple RNA-silencing pathways on GW182/TNRC6.

Molecular cell (2023-06-28)
Thomas Welte, Alison Goulois, Michael B Stadler, Daniel Hess, Charlotte Soneson, Anca Neagu, Chiara Azzi, Marlena J Wisser, Jan Seebacher, Isabel Schmidt, David Estoppey, Florian Nigsch, John Reece-Hoyes, Dominic Hoepfner, Helge Großhans
ZUSAMMENFASSUNG

The RNA-binding protein TRIM71/LIN-41 is a phylogenetically conserved developmental regulator that functions in mammalian stem cell reprogramming, brain development, and cancer. TRIM71 recognizes target mRNAs through hairpin motifs and silences them through molecular mechanisms that await identification. Here, we uncover that TRIM71 represses its targets through RNA-supported interaction with TNRC6/GW182, a core component of the miRNA-induced silencing complex (miRISC). We demonstrate that AGO2, TRIM71, and UPF1 each recruit TNRC6 to specific sets of transcripts to silence them. As cellular TNRC6 levels are limiting, competition occurs among the silencing pathways, such that the loss of AGO proteins or of AGO binding to TNRC6 enhances the activities of the other pathways. We conclude that a miRNA-like silencing activity is shared among different mRNA silencing pathways and that the use of TNRC6 as a central hub provides a means to integrate their activities.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Monoklonaler ANTI-FLAG® M2-Antikörper in Maus hergestellte Antikörper, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)
Millipore
Anti-FLAG® M2 Magnetperlen, affinity isolated antibody
Roche
cOmplete Mini Proteasehemmer-Cocktail, Tablets provided in a glass vial